Search Results - "Bartoni, K"

Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation by Winston, D J, Ho, W G, Lin, C H, Bartoni, K, Budinger, M D, Gale, R P, Champlin, R E

“…The effects of high doses of polyvalent intravenous immune globulin given for prophylaxis of cytomegalovirus infection and interstitial pneumonia in recipients…”
Get more information

Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients by Winston, D J, Ho, W G, Bartoni, K, Champlin, R E

“…The efficacy of i.v. immunoglobulin plus CMV-seronegative blood products or CMV-seronegative blood products alone for prevention of CMV infection, symptomatic…”
Get more information

176: Phase I/II Trial of Bortezomib Maintenance following Autologous Peripheral Blood Progenitor Cell Transplantation as Treatment for Intermediate- and Advanced-Stage Multiple Myeloma by Schiller, G.J, Liao, M, Sohn, J.P, Malone, R, Bartoni, K, Habtemariam, B, Paquette, R, De Vos, S, Territo, M

Get full text

153: Phase I/II trial of bortezomib maintenance following autologous peripheral blood progenitor cell transplantation as treatment for intermediate- and advanced-stage multiple myeloma by Schiller, G.J, Sohn, J.P, Malone, P, Bartoni, K, Habtemariam, B, Paquette, P, deVos, S, Territo, M

Get full text

Updated Results of a Phase I/II Trial of Autologous Peripheral Blood Progenitor Cell Transplantation with Velcade™ Maintenance as Treatment for Intermediate- and Advanced-Stage Multiple Myeloma by Liao, Mickey, Malone, R, Bartoni, K, Habtemariam, B, Paquette, Ronald, de Vos, Sven, Territo, Mary C, Schiller, Gary

“…Pts (median age 59 yrs, range 38–73 yrs) with intermediate- and advanced-stage multiple myeloma were assigned to maintenance therapy with bortezomib beginning…”
Get full text

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients : results of a placebo-controlled, double-blind trial by WINSTON, D. J, HO, W. G, BARTONI, K, DU MOND, C, EBELING, D. F, BUHLES, W. C, CHAMPLIN, R. E

“…To evaluate the efficacy and safety of ganciclovir for prevention of cytomegalovirus (CMV) infection and disease. A randomized, placebo-controlled,…”
Get full text

Elimination of Aspergillus infection in allogeneic stem cell transplant recipients with long-term itraconazole prophylaxis: prevention is better than treatment by Winston, Drew J, Emmanouilides, Christos, Bartoni, Kathy, Schiller, Gary J, Paquette, Ronald, Territo, Mary C

Get full text

Randomized Comparison of Sulbactam/Cefoperazone with Imipenem as Empirical Monotherapy for Febrile Granulocytopenic Patients by Winston, Drew J., Bartoni, Kathy, Bruckner, David A., Schiller, Gary J., Territo, Mary C.

“…In a prospective, randomized, controlled trial, we compared sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile, granulocytopenic…”
Get full text

Use of a polyvalent intravenous immunoglobulin or specific cytomegalovirus hyperimmunoglobulin for modification of cytomegalovirus infections and prevention of interstitial pneumonias following bone marrow transplantation by Winston, D J, Ho, W G, Lin, G H, Bartoni, K, Budinger, M D, Gale, R P, Champlin, R E

“…The effects of prophylactic, polyvalent intravenous immune globulin on cytomegalovirus infection and interstitial pneumonia in allogenic marrow transplants…”
Get more information

Ganciclovir Therapy for Cytomegalovirus Infections in Recipients of Bone Marrow Transplants and Other Immunosuppressed Patients by Drew J. Winston, Winston G. Ho, Kathy Bartoni, Gary N. Holland, Mitsuyasu, Ronald T., Robert P. Gale, Busuttil, Ronald W., Richard E. Champlin

“…The efficacy and safety of ganciclovir were evaluated for the treatment of 39 life-threatening or sight-threatening cytomegalovirus (CMV) infections in…”
Get full text